Utility of genome sequencing in exome‐negative pediatric patients with neurodevelopmental phenotypes
American Journal of Medical Genetics Part A · 2024
DOI: 10.1002/ajmg.a.63817 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2024. Verfasst von Tomoki T Nomakuchi und 16 weiteren Autor:innen. Beteiligte Einrichtung: Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Exome Sequencing, Neurodevelopmental Disorders, Whole Genome Sequencing. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, NHGRI NIH HHS.
Abstract (Originalsprache)
Exome sequencing (ES) has emerged as an essential tool in the evaluation of neurodevelopmental disorders (NDD) of unknown etiology. Genome sequencing (GS) offers advantages over ES due to improved detection of structural, copy number, repeat number and non‐coding variants. However, GS is less commonly utilized due to higher cost and more intense analysis. Here, we present nine cases of pediatric NDD that were molecularly diagnosed with GS between 2017 and 2022, following non‐diagnostic ES. All individuals presented with global developmental delay or regression. Other features present in our cohort included epilepsy, white matter abnormalities, brain malformation and dysmorphic features. Two cases were diagnosed on GS due to newly described gene‐disease relationship or variant reclassification ( MAPK8IP3, CHD3 ). Additional features missed on ES that were later detected on GS were: intermediate‐size deletions in three cases who underwent ES that were not validated for CNV detection, pathogenic variants within the non‐protein coding genes SNORD118 and RNU7‐1 , pathogenic variant within the promoter region of GJB1 , and a coding pathogenic variant within BCAP31 which was not sufficiently covered on ES. GS following non‐diagnostic ES led to the identification of pathogenic variants in this cohort of nine cases, four of which would not have been identified by reanalysis alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Division of Neurology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
- Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
- Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
ORCID-Profile: Tomoki T Nomakuchi, Holly Dubbs
Förderung
- NIGMS NIH HHS
- NIH HHS
- NHGRI NIH HHS
- NINDS NIH HHS
- National Institutes of Health
Zitieren
APA
Nomakuchi, T. T., Teferedegn, E. Y., Li, D., Muirhead, K. J., Dubbs, H., Leonard, J., Muraresku, C., Sergio, E., Arnold, K., Pizzino, A., Skraban, C. M., Zackai, E. H., Wang, K., Ganetzky, R. D., Vanderver, A. L., Ahrens-Nicklas, R. C., & Bhoj, E. J. K. (2024). Utility of genome sequencing in exome‐negative pediatric patients with neurodevelopmental phenotypes. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63817
Vancouver
Nomakuchi TT, Teferedegn EY, Li D, Muirhead KJ, Dubbs H, Leonard J, et al. Utility of genome sequencing in exome‐negative pediatric patients with neurodevelopmental phenotypes. American Journal of Medical Genetics Part A. 2024. doi:10.1002/ajmg.a.63817
BibTeX
@article{Nomakuchi2024,
author = {Nomakuchi, Tomoki T and Teferedegn, Eden Y and Li, Dong and Muirhead, Kayla J and Dubbs, Holly and Leonard, Jacqueline and Muraresku, Colleen and Sergio, Emily and Arnold, Kaley and Pizzino, Amy and Skraban, Cara M and Zackai, Elaine H and Wang, Kai and Ganetzky, Rebecca D and Vanderver, Adeline L and Ahrens-Nicklas, Rebecca C and Bhoj, Elizabeth J K},
title = {Utility of genome sequencing in exome‐negative pediatric patients with neurodevelopmental phenotypes},
journal = {American Journal of Medical Genetics Part A},
year = {2024},
doi = {10.1002/ajmg.a.63817}
}
EUVIMED